Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Both stocks are risky, but one is far less so. This juicy upside potential comes at a cost. Investors seeking stocks with ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Dyadic International Inc (NASDAQ:DYAI) has successfully transitioned from a platform-centric R&D organization to a commercially focused biotechnology company. The company achieved its first commercial ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

Bengaluru-based biotechnology startup CrisprBits Private Limited has raised USD 3 Million through founders, angels & family offices, bringing the company's valuation to $12 Million. The current Pre-Se ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...